Search
Cardinal Health Inc
CAHAdd to Watchlist
221.770USD
-4.370-1.93%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
52.34BMarket Cap
33.77P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Cardinal Health Inc is 8.53, ranking 32 out of 157 in the Pharmaceuticals industry. The average price target is 220.00, with a high of 243.00 and a low of 152.11.
Analyst Rating
Based on
19
analysts
Buy
Current Rating
245.696
Target Price
+8.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Cardinal Health Inc
CAH
19
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Cardinal Health Inc's expected revenue for the next quarter?
Cardinal Health Inc's expected revenue is 65.22B.
What is Cardinal Health Inc's price target?
Analysts forecast that Cardinal Health Inc's price target is USD 220.00, with the highest forecast at USD 243.00 and the lowest forecast at USD 152.11.
How have Cardinal Health IncCAH's recent earnings per share performed?
The market expectation was USD 1.70, while Cardinal Health IncCAH's earnings per share (EPS) for the previous quarter was USD 1.98. EPS for the next quarter is expected at USD 2.41.
What is the analyst rating for Cardinal Health Inc?
Based on the ratings of Cardinal Health Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
